Multi-Range Pharmaceuticals P Ltd
About Multi-Range Pharmaceuticals P Ltd
Data last updated:
Multi-Range Pharmaceuticals P Ltd is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the plastics and polymers sector. It was incorporated on 14 February 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U25209MH1994PTC076573.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹24.46 Lakh. It is led by directors including Minoti Aniket Gore and Aniket Mohan Gore.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Yashwant Sadan102 Dr M Braut Marg Shivaji Park, Mumbai, Maharashtra, India – 400028.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.39 Lakh. For the same year it recorded a net profit of ₹1 Lakh (net margin 72%) and EBITDA of ₹1.24 Lakh (EBITDA margin 89.4%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 6% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressYashwant Sadan102 Dr M Braut Marg Shivaji Park, Mumbai, Maharashtra, India – 400028
- IndustryPlastics, Manufacturing, Pvc, Plastic, Tank, Synthetic
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Multi-Range Pharmaceuticals P Ltd FY 2025 filings available
Multi-Range Pharmaceuticals P Ltd reported revenue of ₹1.39 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR) of Multi-Range Pharmaceuticals P Ltd
Revenue has declined at a compounded annual rate (CAGR) of 6% over five years. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Multi-Range Pharmaceuticals P Ltd
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.24 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Multi-Range Pharmaceuticals P Ltd
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 89.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 72% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Multi-Range Pharmaceuticals P are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Multi-Range Pharmaceuticals P Ltd
Multi-Range Pharmaceuticals P Ltd is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Doctsmedi Pharmaceuticals Private Limited | ₹1.41 Lakh (FY 2024) | •••• | •••• | -69.0% | •••• | Lucknow, Uttar Pradesh, India |
| Novencia Pharmaceuticals Private Limited | ₹1.4 Lakh (FY 2024) | •••• | •••• | •••• | Dehradun, Uttarakhand, India | |
| Scabious Pharmaceuticals Private Limited | ₹1.4 Lakh (FY 2019) | •••• | •••• | 481.0% | •••• | Karnal, Haryana, India |
| Urora Pharmaceuticals Private Limited | ₹1.4 Lakh (FY 2019) | •••• | •••• | •••• | Chennai, Tamil Nadu, India | |
| Bailey Pharmaceuticals Private Limited | ₹1.39 Lakh (FY 2025) | •••• | •••• | •••• | Coimbatore, Tamil Nadu, India | |
| Multi-Range Pharmaceuticals P Ltd this company | ₹1.39 Lakh (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Carewinds Pharmaceuticals Private Limited | ₹1.39 Lakh (FY 2021) | •••• | •••• | •••• | Coimbatore, Tamil Nadu, India | |
| PJP Pharmaceuticals Private Limited | ₹1.38 Lakh (FY 2025) | •••• | •••• | -35.0% | •••• | Nagpur, Maharashtra, India |
| Abc Pharmaceuticals Private Limited | ₹1.38 Lakh (FY 2024) | •••• | •••• | 38483.0% | •••• | Patiala, Punjab, India |
| Adinah Pharmaceuticals Private Limited | ₹1.38 Lakh (FY 2025) | •••• | •••• | •••• | Lucknow, Uttar Pradesh, India | |
| Cogent Pharmaceuticals Private Limited | ₹1.37 Lakh (FY 2016) | •••• | •••• | -14.0% | •••• | Muradnagar, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Multi-Range Pharmaceuticals P by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Multi-Range Pharmaceuticals P Ltd
Multi-Range Pharmaceuticals P Ltd is audited by HMA & Associates for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| HMA & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Multi-Range Pharmaceuticals P Ltd
Multi-Range Pharmaceuticals P has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Minoti Aniket Gore | Director | 01 Jun 2017 | 9 Years 4 Months | Current |
| Aniket Mohan Gore | Director | 31 Aug 1997 | 29 Years 1 Months | Current |
| Mohan Atmaram Gore | Director | 31 Aug 1997 | 29 Years 1 Months | Current |
Ownership and Shareholding of Multi-Range Pharmaceuticals P Ltd
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Multi-Range Pharmaceuticals P Ltd
Multi-Range Pharmaceuticals P Ltd does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Multi-Range Pharmaceuticals P Ltd
Employment history and EPFO contributions of people linked to Multi-Range Pharmaceuticals P.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Multi-Range Pharmaceuticals P Ltd
Multi-Range Pharmaceuticals P has 1 associated company. This group structure data is as of FY 2017. The table lists each entity with its relationship and holding.
Recent Activity on Multi-Range Pharmaceuticals P Ltd
Multi-Range Pharmaceuticals P Ltd has 4 board changes on record since 1997: 3 appointments and 1 cessation. The latest: Minoti Aniket Gore ceased to be Additional Director on 29 Sep 2017.
Credit Ratings, Litigation & Regulatory Alerts for Multi-Range Pharmaceuticals P Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Multi-Range Pharmaceuticals P Ltd
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Multi-Range Pharmaceuticals P Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Multi-Range Pharmaceuticals P Ltd
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Multi-Range Pharmaceuticals P Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Multi-Range Pharmaceuticals P Ltd
Multi-Range Pharmaceuticals P is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the plastics industry. It was incorporated on 14 February 1994 (32+ years old) and is registered under CIN U25209MH1994PTC076573.
Multi-Range Pharmaceuticals P reported revenue of ₹1.39 Lakh for FY 2025.
Multi-Range Pharmaceuticals P has 3 current directors:
- Minoti Aniket Gore - Director
- Aniket Mohan Gore - Director
- Mohan Atmaram Gore - Director
Multi-Range Pharmaceuticals P reported a net profit of ₹1 Lakh (net margin 72%) and EBITDA of ₹1.24 Lakh (EBITDA margin 89.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Multi-Range Pharmaceuticals P is -5% over three years and -6% over five years. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Multi-Range Pharmaceuticals P is U25209MH1994PTC076573. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Multi-Range Pharmaceuticals P was incorporated on 14 February 1994, making it 32+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Multi-Range Pharmaceuticals P by revenue are Doctsmedi Pharmaceuticals Private Limited, Novencia Pharmaceuticals Private Limited, Scabious Pharmaceuticals Private Limited, Urora Pharmaceuticals Private Limited, Bailey Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Minoti Aniket Gore ceased to be Additional Director on 29 Sep 2017. Minoti Aniket Gore was appointed as Director on 01 Jun 2017. Aniket Mohan Gore was appointed as Director on 31 Aug 1997. Multi-Range Pharmaceuticals P has 4 board changes on record in total.
The registered office of Multi-Range Pharmaceuticals P is at Yashwant Sadan102 Dr M Braut Marg Shivaji Park, Mumbai, Maharashtra, India – 400028.
Multi-Range Pharmaceuticals P has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹24.46 Lakh.